India's Divi's Laboratories rises to record high on quarterly profit jump
BUZZ-India's Divi's Laboratories rises to record high on quarterly profit jump ** Shares of India's Divi's Laboratories DIVI.NS rise 4.3% to a record high of 8,404.50 rupees
** The drugmaker on Saturday reported first-quarter profit up 65.5% y/y; revenue from operations up 27.8% y/y
** Citi ("buy") revises TP up to 11,700 rupees from 9,450 rupees, says EBITDA margins expanded 72% y/y due to strong custom synthesis business
** Jefferies ("buy") revises TP up to 10,200 rupees from 7,950 rupees, says company outlook remains strong with "best in class pipeline"
** Morgan Stanley ("overweight") revises TP up to 9,111 rupees from 7,904 rupees
** Brokerage expects strong first-quarter and H2FY27 project ramp-ups to drive ~20% revenue growth
** DIVI on avg rated "hold"; median PT is 6,921 rupees - LSEG-compiled data
** Stock up 31.5%, YTD
(Reporting by Abhirami G in Bengaluru)
Recent news on Divi's Laboratories
See all newsDivi's Laboratories and Laurus Labs lead India's record CRDMO growth, Jefferies says
India Stocks: Indian shares inch higher to close at 8-month high as crude oil drops
India's Divi's Laboratories jumps to record high after profit jumps by nearly two thirds
Indian shares muted as markets pause after last week's rally
India Stocks: Indian shares consolidate in Diwali session after seven-day rally